Successful Treatment of Nephrotic Syndrome Due To Fmf Amyloidosis With Azathioprine: Report of Three Turkish Cases
No Thumbnail Available
Date
2006
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Heidelberg
Abstract
Secondary amyloidosis is a well-known complication of certain familial Mediterranean fever (FMF). We presented three Turkish patients with FMF and biopsy proven amyloidosis. These patients were treated with colchicine 1.5 mg/day. They have experienced five to six peritonitis attacks with fever within 1 year. On admission, the laboratory test results were as follows: serum creatinine 2.3, 0.6, and 0.5 mg/dl; albumin 4.2, 1.9, and 1.8 g/dl; and urinary protein excretion 4, 15, and 10 g/day, respectively. All the patients were started azathioprine (AZA) 100 mg/day and attacks were completely stopped. Laboratory findings were as follows after I year of AZA treatment: serum creatinine 1, 0.8, and 0.6 mg/dl; albumin 4.3, 3, and 3.5 g/dl; and urinary protein excretion 3, 8, and 1.5 g/day, respectively. Treatment with azathioprine in addition to colchicine could ameliorate the nephrotic syndrome and control the attacks very effectively in these cases.
Description
Reha, Erkoc/0009-0001-7230-8843; Sayarlioglu, Mehmet/0000-0001-6214-1974
Keywords
Fmf, Secondary Amyloidosis, Azathioprine
Turkish CoHE Thesis Center URL
WoS Q
Q2
Scopus Q
Q2
Source
Volume
27
Issue
2
Start Page
197
End Page
199